v. 104 (2009)

Current status and perspectives of cell therapy in Chagas disease

The BENEFIT trial: testing the hypothesis that trypanocidal therapy is beneficial for patients with chronic Chagas heart disease

Ergosterol biosynthesis and drug development for Chagas disease

Experimental chemotherapy for Chagas disease: 15 years of research contributions from in vivo and in vitro studies

Proline racemases: insights into Trypanosoma cruzi peptides containing D-proline

Protective immunity against Trypanosoma cruzi

Swimming against the current: genetic vaccination against Trypanosoma cruzi infection in mice

Perspectives of vaccination in Chagas disease revisited

α-N-acetylglucosamine-linked O-glycans of sialoglycoproteins (Tc-mucins) from Trypanosoma cruzi Colombiana strain

Two approaches to discovering and developing new drugs for Chagas disease

The importance of apoptosis for immune regulation in Chagas disease

Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy

Innate immunity and regulatory T-cells in human Chagas disease: what must be understood?

The effects of nitric oxide on the immune system during Trypanosoma cruzi infection

Chronic Trypanosoma cruzi-elicited cardiomyopathy: from the discovery to the proposal of rational therapeutic interventions targeting cell adhesion molecules and chemokine receptors - how to make a dream come true

Chagas disease, adipose tissue and the metabolic syndrome

Cellular and genetic mechanisms involved in the generation of protective and pathogenic immune responses in human Chagas disease

Do Archaea and bacteria co-infection have a role in the pathogenesis of chronic chagasic cardiopathy?

Back to the future in Chagas disease: from animal models to patient cohort studies, progress in immunopathogenesis research

All-around care for patients with Chagas disease: a challenge for the XXI century

Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina

Morbidity and prognostic factors in chronic chagasic cardiopathy

Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification

The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives

Viability study of a multiplex diagnostic platform for Chagas disease

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies?

Trypanosoma cruzi: ancestral genomes and population structure

Molecular mechanisms of Trypanosoma cruzi infection by oral route

Structural organization of Trypanosoma cruzi

A century of research: what have we learned about the interaction of Trypanosoma cruzi with host cells?

Sylvatic triatominae: a new challenge in vector control transmission

Exploiting triatomine behaviour: alternative perspectives for their control

Wild Triatoma infestans, a potential threat that needs to be monitored

Sustainability of vector control strategies in the Gran Chaco Region: current challenges and possible approaches

Biology, diversity and strategies for the monitoring and control of triatomines - Chagas disease vectors

Elimination of Chagas disease transmission: perspectives

Epidemiology, control and surveillance of Chagas disease: 100 years after its discovery

Current epidemiological trends for Chagas disease in Latin America and future challenges in epidemiology, surveillance and health policy

Paleoparasitology of Chagas disease: a review

Chagas disease centennial anniversary celebration: historical overview and prospective proposals aiming to maintain vector control and improve patient prognosis - a permanent challenge

Foreword

International symposium on the Centennial of the discovery of Chagas disease

Inscrever-se em v. 104 (2009)